Square Pharmaceuticals’ annual profit grows by 19.38% | The Business Standard
Skip to main content
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
July 22, 2025

Sign In
Subscribe
  • Latest
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Get the Paper
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JULY 22, 2025
Square Pharmaceuticals’ annual profit grows by 19.38%

Corporates

TBS Report
21 October, 2021, 09:20 pm
Last modified: 21 October, 2021, 09:23 pm

Related News

  • Square Pharma MD Tapan Chowdhury purchases 15 lakh shares
  • Square Pharma vice chairman to purchase shares worth Tk33cr
  • Square Pharma directors acquire Tk280cr shares since 2020
  • Square Pharma MD to buy company shares worth Tk32.55cr
  • Square Pharma director to buy company shares worth Tk32cr

Square Pharmaceuticals’ annual profit grows by 19.38%

60% cash dividend recommended for 2020-21

TBS Report
21 October, 2021, 09:20 pm
Last modified: 21 October, 2021, 09:23 pm
Square Pharma maintained an average of 18.4 percent annual profit growth over the last seven years/Photo: Courtesy
Square Pharma maintained an average of 18.4 percent annual profit growth over the last seven years/Photo: Courtesy

Square Pharmaceuticals Ltd posted Tk1,594 crore in annual profit for the 2020-21 fiscal year, which is 19.38% higher compared to the previous year.

The profit growth boosted the top pharmaceutical company's earnings per share to Tk17.99 for the year, up from the previous year's Tk15.07.

The profit figures include that of its subsidiary companies. But the individual companies also posted growth in profits on a standalone basis.

The Business Standard Google News Keep updated, follow The Business Standard's Google news channel

Square Company Secretary Khandaker Habibuzzaman declined to comment beyond the disclosures after the board meeting.

However, one of his colleagues told The Business Standard that the company secured double digit revenue growth in the 2020-21 fiscal year, both on a standalone and consolidated basis.  

At the end of June this year, Square Pharma and its subsidiaries' combined net asset value per share stood at Tk102.54.

Square Pharmaceuticals board of directors recommended a 60% cash dividend for its shareholders, which would cost the company less than half of its annual profit.

Its board of directors also approved a Tk300 crore investment plan for BMRE (balancing, modernising, rehabilitation and expansion), buying new capital machinery and land for future expansion.

In its upcoming annual general meeting scheduled to be held on 15 December virtually, shareholders would consider the dividend plan and other agenda. Record date to identify shareholders is fixed on 22 November.

Square Pharmaceuticals had been waiting to begin manufacturing in its newly built Kenyan plant in August this year.

The company official who talked to The Business Standard seeking anonymity said, Due to the pandemic situation the commencement of operation abroad was delayed and he is expecting to begin production in the African plant at the end of this year.

The offshore plant is set to help the company diversify its supply chain and mitigate any impact of Bangladesh's LDC graduation a decade later.

Launched in 1958, Square Pharmaceuticals emerged as the industry leader in the mid-1980s and still holds the crown with around 17% market share.

The company got listed on the local bourse in 1995. Square Pharma shares closed 1.1% higher at Tk233.8 in the Dhaka Stock Exchange on Thursday.

The pharma market of the country is growing by 15% every year, according to the Bangladesh Association of Pharmaceutical Industries. The market is expected to grow four times to Tk1 lakh crore by 2030.

 

Economy / Top News

Square Pharmaceuticals / Square Pharmaceuticals Ltd

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Photo: CA Press Wing
    CA Yunus holds meeting with leaders of four major political parties
  • Photo: Syed Zakir Hossain/TBS
    Secretariat protest: 75 injured in police-protester clash over edu adviser's resignation for delaying HSC rescheduling
  • Bangladesh win nail-biter to clinch series win 
    Bangladesh win nail-biter to clinch series win 

MOST VIEWED

  • Training aircraft crashes at the Diabari campus of Milestone College on 21 July 2025. Photo: Courtesy
    BAF jet crash at Milestone school: At least 20 including children, pilot dead; 171 hospitalised
  • Flight Lieutenant Md Towkir Islam. Photo: Collected
    Pilot tried to avoid disaster by steering crashing jet away from populated area: ISPR
  • An idle luxury: Built at a cost of Tk450 crore, this rest house near Parki Beach in Anwara upazila has stood unused for six months. Perched on the southern bank of the Karnaphuli, the facility now awaits a private lease as the Bridge Division seeks to put it to use. Photo: Md Minhaz Uddin
    Karnaphuli Tunnel’s service area holds tourism promises, but tall order ahead
  • Bangladesh declares one-day state mourning following plane crash on school campus
    Bangladesh declares one-day state mourning following plane crash on school campus
  • 91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
    91-day treasury bills rate falls 1.13 percentage points to 10.45% in a week
  • Air Force F-7 BJI training aircraft crashes at Milestone College in Uttara
    Air Force F-7 BJI training aircraft crashes at Milestone College in Uttara

Related News

  • Square Pharma MD Tapan Chowdhury purchases 15 lakh shares
  • Square Pharma vice chairman to purchase shares worth Tk33cr
  • Square Pharma directors acquire Tk280cr shares since 2020
  • Square Pharma MD to buy company shares worth Tk32.55cr
  • Square Pharma director to buy company shares worth Tk32cr

Features

Photo: Mehedi Hasan/TBS

Milestone plane crash: Aggrieved nation left with questions as citizens rally to help

5h | Panorama
Illustration: TBS

Uttara, Jatrabari, Savar and more: The killing fields that ran red with July martyrs’ blood

22h | Panorama
Despite all the adversities, girls from the hill districts are consistently pushing the boundaries to earn repute and make the nation proud. Photos: TBS

Ghagra: Where dreams rise from dust for Bangladesh women's football

2d | Panorama
Photos: Collected

Water-resistant footwear: A splash of style in every step

2d | Brands

More Videos from TBS

Which other party participated in the meeting with the Chief Advisor?

Which other party participated in the meeting with the Chief Advisor?

22m | TBS Today
Milestone Tragedy: Why the different views on the need for blood?

Milestone Tragedy: Why the different views on the need for blood?

1h | TBS Today
News of The Day, 22 JULY 2025

News of The Day, 22 JULY 2025

2h | TBS News of the day
US can avoid competition with China?

US can avoid competition with China?

1h | Others
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net